Scavenger receptor BI attenuates oxidized phospholipid-induced pulmonary inflammation.

Saved in:
Bibliographic Details
Title: Scavenger receptor BI attenuates oxidized phospholipid-induced pulmonary inflammation.
Authors: Dunigan-Russell K; Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States., Yaeger MJ; Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States., Hodge MX; Department of Pharmacology and Toxicology, East Carolina University, Greenville, NC, United States., Kilburg-Basnyat B; Department of Pharmacology and Toxicology, East Carolina University, Greenville, NC, United States., Reece SW; Department of Pharmacology and Toxicology, East Carolina University, Greenville, NC, United States., Birukova A; Department of Medicine, Duke University Medical Center, Durham, NC, United States., Guttenberg MA; Department of Medicine, Duke University Medical Center, Durham, NC, United States., Novak C; Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States., Chung S; Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States., Ehrmann BM; Deparment of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Wallace ED; Deparment of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Tokarz D; Experimental Pathology Laboratories, Inc., Research Triangle Park, NC, United States., Majumder N; Department of Physiology and Pharmacology, West Virginia University, Morgantown, WV, United States., Xia L; College of Human and Health Sciences, Purdue University, West Lafayette, IN, United States., Christman JW; Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States., Shannahan J; College of Human and Health Sciences, Purdue University, West Lafayette, IN, United States., Ballinger MN; Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States., Hussain S; Department of Physiology and Pharmacology, West Virginia University, Morgantown, WV, United States., Shaikh SR; Department of Nutrition, Gillings School of Global Public Health and School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Tighe RM; Department of Medicine, Duke University Medical Center, Durham, NC, United States., Gowdy KM; Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States. Electronic address: kymberly.gowdy@osumc.edu.
Source: Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2023 Mar 01; Vol. 462, pp. 116381. Date of Electronic Publication: 2023 Jan 19.
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0416575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0333 (Electronic) Linking ISSN: 0041008X NLM ISO Abbreviation: Toxicol Appl Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1096-0333
DOI:10.1016/j.taap.2023.116381